Carole D. Gleeson

Carole D. Gleeson has extensive experience in the pharmaceutical and biotech industries, focusing on market research and commercial insights. Carole D. has held various director-level positions at companies such as Rhythm Pharmaceuticals, The Janssen Pharmaceutical Companies of Johnson & Johnson, Momenta Pharmaceuticals, EMD Serono, Alkermes, and AMAG Pharmaceuticals. Carole has also worked as a senior analyst at Boston Scientific and as a pharmaceutical industry consultant at Decision Resources. Carole D.'swork experience includes roles in market assessments, market research, product strategy, commercial planning, and new product planning. Carole has expertise in areas such as rare genetic diseases of obesity, autoimmune diseases, neurology, immunology, and metabolic disorders. Carole D. has a strong background in conducting primary and secondary research, providing insights through data analysis, and contributing to commercial strategic plans.

Carole D. Gleeson holds a Master of Business Administration (MBA) degree with a focus on Entrepreneurship from Babson F.W. Olin Graduate School of Business. Carole D. also has a Master of Science (MS) degree in Infectious Disease Epidemiology and Immunology from Harvard T.H. Chan School of Public Health. Carole completed their undergraduate education at Tufts University, earning a Bachelor of Science (BS) degree in Biology. Prior to their college education, they attended The Bronx High School of Science for their high school studies.